Baicalin and geniposide inhibit the development of atherosclerosis by increasing Wnt1 and inhibiting dickkopf-related protein-1 expression

Journal of Geriatric Cardiology

Volumn 13, Issue 10, 2016, Pages 846-854

  Wang, Bin ^a   Liao, Ping Ping ^a   Liu, Li Hua ^a   Fang, Xin ^a   Li, Wei ^a   Guan, Si Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Atherosclerosis; Baicalin; DKK1; Geniposide; Wnt1

Indexed keywords

BAICALIN; DICKKOPF 1 PROTEIN; GENIPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; WNT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIATHEROSCLEROTIC ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84999666605     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.11909/j.issn.1671-5411.2016.10.013     Document Type: Article

References (33)

1. Antoniades C, Antonopoulos AS, Bendall JK, et al. Targeting redox signaling in the vascular wall: from basic science to clinical practice. Curr Pharm Des 2009; 15: 329-342.
2. Peifer M, Polakis P. Wnt signaling in oncogenesis and embryogenesis: a look outside the nucleus. Science 2000; 287: 1606-1609.
3. Reis M, Liebner S. Wnt signaling in the vasculature. Exp Cell Res 2013; 319: 1317-1323.
4. Sen M, Ghosh G. Transcriptional outcome of Wnt-Frizzled signal transduction in inflammation: evolving concepts. J Immunol 2008; 181: 4441-4445.
5. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006; 25: 7469-7481.
6. Tsaousi A, Mill C, George SJ. The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol 2011; 22: 350-357.
7. Gherghe CM, Duan J, Gong J, et al. Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner. FASEB J 2011; 25: 1836-1843.
8. Goliasch G, Wiesbauer F, Kastl SP, et al. Premature myocardial infarction is associated with low serum levels of Wnt-1. Atherosclerosis 2012; 222: 251-256.
9. Ueland T, Otterdal K, Lekva T, et al. Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 1228-1234.
10. Kim KI, Park KU, Chun EJ, et al. A novel biomarker of coronary atherosclerosis: serum DKK1 concentration correlates with coronary artery calcification and atherosclerotic plaques. J Korean Med Sci 2011; 26: 1178-1184.
11. Seifert-Held T, Pekar T, Gattringer T, et al. Circulating Dickkopf-1 in acute ischemic stroke and clinically stable cerebrovascular disease. Atherosclerosis 2011; 218: 233-237.
12. Wang B, Guan SM, Li XD. Effects of micrometer compound rhizoma inflammatory factors in rabbit coptidis on nuclear factor-KB and fed with lipid diet. Zhongguo Zhongyao zazhi 2007; 32: 1207-1210.
13. Kim DH, Kim HK, Park S, et al. Short-term feeding of baicalin inhibits age-associated NF-?B activation. Mech Ageing Dev 2006; 127: 719-725.
14. Liao P, Liu L, Wang B, et al. Baicalin and geniposide attenuate atherosclerosis involving lipids regulation and immunoregulation in ApoE-/-mice. Eur J Pharmacol 2014; 740: 488-495.
15. Liu L, Liao P, Wang B, et al. Oral administration of baicalin and geniposide induces regression of atherosclerosis via inhibiting dendritic cells in ApoE-knockout mice. Int Immunopharmacol 2014; 20: 197-204.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoproteincholesterol inplasma, withoutuse of the preparative ultracentrifuge. Clin Chem 1972;18: 499-502.
17. Paigen B, Morrow A, Holmes PA et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987; 68: 231-240.
18. Guan S, Wang B. Effects of fosinopril and valsartan on expressions of ICAM-1 and NO in human umbilical vein endothelial cells. Chin Med J (Engl) 2003; 116: 923-927.
19. Wang GF, Wu SY, Xu W. Geniposide inhibits high glucoseinduced cell adhesion through the NF-?B signaling pathway in human umbilical vein endothelial cells. Acta Pharmacol Sin 2010; 31: 953-962.
20. Waisundara VY, Siu SY, Hsu A, et al. Baicalin upregulates the genetic expression of antioxidant enzymes in type-2 diabetic Goto-Kakizaki rats. Life Sci 2011; 88: 1016-1025.
21. Zhang SC, Liu XQ, Chen HQ, et al. The regulated effects of baicalin on NF-?B and ACE2 protein expression in atherosclero sis of ApoE-/-mice induced by hiperlipemia. Chin Hosp Pharm J 2013; 33: 1-4.
22. Lee DK, Nathan GR, Trachte AL, et al. Activation of the canonical Wnt/beta-catenin pathway enhances monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 2006; 347: 109-116.
23. Pereira C, Schaer DJ, Bachli EB, et al. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 2008; 28: 504-510.
24. Blumenthal A, Ehlers S, Lauber J, et al. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 2006; 108: 965-973.
25. Masckauchan TN, Shawber CJ, Funahashi Y, et al. Wnt/betacatenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 2005; 8: 43-51.
26. Goodwin AM, Sullivan KM, D'Amore PA. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev Dyn 2006; 235:3110-3120.
27. Yu B, Chang J, Liu Y, et al. Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-?B. Nat Med 2014; 20: 1009-1017.
28. Marinou K, Christodoulides C, Antoniades C, et al. Wnt signaling in cardiovascular physiology. Trends Endocrinol Metab 2012; 23: 628-636.
29. Collins T, Cybulsky MI. NF-?B: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 2001; 107: 255-264.
30. Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine-mediated NF-?B activation and proinflammatory gene expression by inhibiting inhibitory factor I?B kinase activity. J Immunol 1999; 163: 3474-3483.
31. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-?B activity. Annu Rev Immunol 2000; 18: 621-663.
32. Hauer AD, Vyttenhore C, de Vos P, et al. Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation 2005; 112: 1054-1062.
33. Wegner M, Winiarska H, Bobkiewicz-Kozlowska T et al. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine 2008; 42: 312-316.